Full Text Journal Articles by
Author Robert Stirrups

Advertisement

Find full text journal articles






Marquita Genies.

Robert Stirrups,

Lancet Child Adolesc Health (The Lancet. Child & adolescent health)
[2020, 4(12):861]

Cited: 0 times

View full text PDF listing >>



The mother of invention

Robert Stirrups,

Lancet Infect Dis (The Lancet. Infectious diseases)
[2020, 20(11):1245-1245]

Cited: 0 times

View full text PDF listing >>



Advertisement

Mijna Hadders-Algra.

Robert Stirrups,

Lancet Child Adolesc Health (The Lancet. Child & adolescent health)
[2020, 4(3):181]

Cited: 0 times

View full text PDF listing >>



CAR T-cell therapy for relapsed or refractory mantle-cell lymphoma.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2020, 21(5):e239]

Cited: 0 times

View full text PDF listing >>



Dasatinib versus imatinib for childhood acute lymphocytic leukaemia.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2020, 21(2):e73]

Cited: 0 times

View full text PDF listing >>



Pembrolizumab for triple-negative breast cancer.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2020, 21(4):e183]

Cited: 0 times

View full text PDF listing >>



Abemaciclib plus fulvestrant for breast cancer.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(11):e617]

Cited: 0 times

View full text PDF listing >>



Sight reveals itself.

Robert Stirrups,

Lancet Neurol (The Lancet. Neurology)
[2020, 19(1):36]

Cited: 0 times

View full text PDF listing >>



Metformin plus EGFR TKIs for lung adenocarcinoma.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(10):e563]

Cited: 0 times

View full text PDF listing >>



Selinexor-dexamethasone for refractory multiple myeloma.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(10):e560]

Cited: 0 times

View full text PDF listing >>



Ibrutinib and rituximab for chronic lymphocytic leukaemia.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(9):e471]

Cited: 1 time

View full text PDF listing >>



Idelalisib and rituximab for chronic lymphocytic leukaemia.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(6):e294]

Cited: 0 times

View full text PDF listing >>



Clofarabine and cytarabine for acute myeloid leukaemia.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(8):e402]

Cited: 0 times

View full text PDF listing >>



CAR T-cell therapy for relapsed or refractory multiple myeloma.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(6):e297]

Cited: 0 times

View full text PDF listing >>



Lapatinib with chemotherapy for gastro-oesophageal cancer.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(8):e400]

Cited: 0 times

View full text PDF listing >>



Alpelisib plus fulvestrant for PIK3CA-mutated breast cancer.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(7):e347]

Cited: 1 time

View full text PDF listing >>



Axitinib combination therapies versus sunitinib for renal cell carcinoma.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(3):e141]

Cited: 0 times

View full text PDF listing >>



Minimally invasive oesophagectomy for oesophageal cancer.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(2):e74]

Cited: 0 times

View full text PDF listing >>



Neratinib and capecitabine for breast cancer brain metastases.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(4):e197]

Cited: 0 times

View full text PDF listing >>



Atezolizumab for metastatic triple-negative breast cancer.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2018, 19(10):e519]

Cited: 1 time

View full text PDF listing >>



Sacituzumab govitecan-hziy for triple-negative breast cancer.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2019, 20(4):e194]

Cited: 1 time

View full text PDF listing >>



Surveillance imaging of Wilms' tumours.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2018, 19(12):e670]

Cited: 0 times

View full text PDF listing >>



Brigatinib versus crizotinib for ALK-positive NSCLC.

Robert Stirrups,

Lancet Oncol. (The Lancet. Oncology)
[2018, 19(11):e585]

Cited: 1 time

View full text PDF listing >>



The storm and stress in the adolescent brain.

Robert Stirrups,

Lancet Neurol (The Lancet. Neurology)
[2018, :]

Cited: 0 times

View full text PDF listing >>



HPV status and oesophageal adenocarcinoma.

Robert Stirrups,

Lancet Oncol (The Lancet. Oncology)
[2018, 19(9):e443]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
0.763 s